Novel Alzheimer’s drug candidate reduces inflammation and protects neurons

Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the University of Barcelona has developed a promising therapeutic candidate to treat this disease, which affects more than 800,000 people in Spain.

Leave A Comment

Your email address will not be published. Required fields are marked *